PYC THERAPEUTICS LIMITED — Director's Dealing 2016

Sep 11, 2016

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity PHYLOGICA LIMITED ACN 098 391 961

We Swiftel Limited give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	PAUL WATT
Date of Appointment	12thSeptember 2016

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Number & class of securities

4,044,123 Ordinary Shares

• See chapter 19 for defined terms.

30/9/2001

Appendix 3X Page 1

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

	Name of holder & nature of interestNote: Provide details of the circumstances givingrise to the relevant interest.PAULMICHAELWATT&MARIA DEL PILAR ENRIQUEZ-WATT ATF THE BRAINCHILDSUPER FUNDTrustee & Fund BeneficiaryMaria Del PilarWife	Number & class of Securities10,473,074 Ordinary Shares9,000,000 Ordinary Shares

Part 3 – Director’s interests in contracts

Detail of contract	NIL
Nature of interest
Name of registered holder(if issued securities)
No. and class of securities to whichinterest relates

• See chapter 19 for defined terms.

Appendix 3X Page 2

30/9/2001